AcuamarkDx

New York, NY · Founded 2012 · Privately Held (backing)

Developer of a cancer screening blood technology designed to detect cancer markers at early stages. AcuamarkDx is based in New York, NY and was founded in 2012. Its last reported valuation was $85 million in Jun 2024. It has raised $25 million.

Last reported valuation
$85.0M
Oct 2026
Priced at
—
Total raised
$25.0M
Last round
—

Who backs AcuamarkDx?

5 investors
InvestorType
1955 Capital—
Bruker—
Cornell University—
HBS Alumni Angels of Greater New York—
XLerateHealth—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

AcuamarkDx investors

5 investors are on record for AcuamarkDx, including 1955 Capital, Bruker, Cornell University and HBS Alumni Angels of Greater New York.

Free account
More of AcuamarkDx with a free account
  • ·Watch AcuamarkDx: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 5 firms already write checks for companies like AcuamarkDx. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View